SecurityEVIO / EVIO, Inc.
CEOWaldrop William
IndustryCannabis and Medical Marijuana Dispensaries
Institutional Owners0
Common Shares Outstanding20,098,235 shares (as of 2018-06-30)

Institutional Stock Ownership and Shareholders

EVIO, Inc. (OTC:EVIO) has 0 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). Largest shareholders include .
EVIO, Inc. (OTC:EVIO) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

Important Note!
Note: We do not currently have a CUSIP on file for this security. That means we are unable to search institutional fund filings (13F's) for this company, which means there may be institutional holders that we are unaware of. If you know the CUSIP or would like us to research and update this security, please let us know by leaving a message in the Welcome Group.
File DateFormInvestor Opt Prev
Prev Value
Current Value

Related News Stories

Weekly Cannabis Report: Tilray Is Damaging The Entire Pot Sector

2018-09-24 seekingalpha
Cannabis stocks continued to show momentum despite a sell-off on Thursday and Friday driven by Tilray's spectacular rise and fall. (6-2)

The Best 'Pick And Shovel' Plays Of Cannabis (Part II)

2018-09-21 seekingalpha
In this article, we will discuss three more companies that all focus on the technologies that can be used in the cannabis industry. (10-1)

Plays On Picks And Shovels In The Cannabis Industry

2018-06-12 seekingalpha
Because of the company’s role as a tester, EVIO is expected to benefit from regulatory overhang unlike other companies in the industry. (18-0)